MedPath

Haskap and Endurance Running Performance

Not Applicable
Completed
Conditions
Exercise Performance
Interventions
Dietary Supplement: Haskapa
Dietary Supplement: Placebo
Registration Number
NCT04837898
Lead Sponsor
Northumbria University
Brief Summary

This study will employ a randomised, double-blind, placebo-controlled, independent groups experimental design. Submaximal, maximal and 5 km time trial running performance will be assessed before and after supplementation with haskap berry or a placebo.

Detailed Description

Participants will consume haskap berry powder or an isocaloric placebo for 7 days. They will be required to run on a treadmill before and after supplementation to asses the influence on the intervention on aerobic performance parameters. Other performance parameters such as blood lactate, heart rate, ratings of perceived exertion and respiratory variables will also be monitored throughout the various elements of the exercise trials.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
30
Inclusion Criteria
  • healthy non-smoking males
  • completed a 5 km run (in less than 25 minutes) within the 6 weeks prior to the study
Exclusion Criteria
  • female
  • allergies to fruit or dairy, currently taking any nutritional supplements (e.g. vitamins, antioxidant, herbal or sports enhancing supplements) or medication that might affect the study outcome
  • history of gastrointestinal, renal or cardiovascular disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Haskap berryHaskapaA commercially available haskap berry freeze-dried) powder
PlaceboPlaceboBlack cherry KoolAid (Kraft Foods, USA) with added maltodextrin to match carbohydrate and calorie content
Primary Outcome Measures
NameTimeMethod
V̇O2peak testChange from baseline at 7 days

time to exhaustion (seconds)

5km time trialChange from baseline at 7 days

time to complete the trial (seconds)

Secondary Outcome Measures
NameTimeMethod
VO2 during submaximal tests, maximal testsChange from baseline at 7 days

(oxygen uptake - relative ml/kg/min and absolute l/min)

Blood lactate response during submaximal tests, maximal and time trialChange from baseline at 7 days

lactate (mmol/L)

rating of perceived exertion during submaximal tests, maximal and time trialChange from baseline at 7 days

RPE (/20)

heart rate during submaximal tests, maximal and time trialChange from baseline at 7 days

(BPM)

Trial Locations

Locations (1)

Northumbria University

🇬🇧

Newcastle Upon Tyne, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath